Purpose, Vision and Mission
Providing Smart Solutions for Chronic Healthcare
We are a healthcare company guided by a shared purpose of helping people stay in good health. Good health means more than just avoiding severe illness or hospitalization, which also means the health-related problems people face in their daily lives are addressed, treated and prevented.
We want to give people control over their chronic healthcare. By empowering them to make smarter solutions, we believe that we can increase their quality of life and help them live their lives to the fullest. We call these smart solutions for chronic healthcare. We are driven by high ambitions to become a leading force in healthcare area.
Therapeutic Areas
We own and commercialize a range of
documented and trusted brands
within key therapeutic areas
Benvue at a Glance
We own and commercialize original EU products
Being a strategic partner of Italian Pharmaceutical Company, our products are available in more than 50 countries
2012
Journey started with River Pharma Srl, Italy
2014
Journey started with Lisa Pharma SpA, Italy
2016
Journey started with Sialor Milano, Italy
2016
Journey started with Pu Yuan Biotech Co. Ltd, Taiwan
2018
Journey started with Savio Industrial Srl, Italy
2022
Journey started with Biodue SpA, Italy
2025
Journey started with Bionativa SpA, Italy
Our Global Partners
“We are dedicated to leading in Chronic healthcare through strategic innovation, a consumer-centric approach, and omnichannel excellence”
Md. Anisur Rahman
Managing Director & CEO
Our Sustainability Commitments
Benvue is committed to operate in a responsible and sustainable manner over time and in a way that contributes to a positive, trust-based relationship between Benvue, our stakeholders and society as a whole.
Corporate responsibility is deeply rooted in our culture and in the way we work. Benvue has defined four sustainability commitments which guide us in acting responsibly in all parts of our business and in our relations with our surroundings.
News
14 October, 2025
11 million lives lost each year: urgent action needed on neurological care
The World Health Organization (WHO) today warns that less than one in three countries around the world has a national policy to address the growing burden of neurological disorders, responsible for over 11 million deaths globally each year. The WHO’s new Global status report on neurology released today shows that neurological conditions now affect more than 40% of the global population – over 3 billion people.
The top 10 neurological conditions contributing to death and disability as of 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer’s disease and other dementias, diabetic neuropathy . . . . .
14 October, 2025
WHO and the European Union launch collaboration to advance digitized health systems in sub-Saharan Africa
The World Health Organization (WHO) and the European Union (EU) announced today a new agreement to support the digital transformation of health systems and wider adoption of WHO’s Global Digital Health Certification Network (GDHCN) in sub-Saharan Africa. This EU–WHO partnership will improve pandemic preparedness and accelerate progress towards better health and well-being for all.
The agreement was announced at the World Health Summit 2025 . . . . .
We Support Operation Smile
Every three minutes, a child with a cleft lip or palate is born. These children often live a tough life, having to endure harassment and isolation.
Operation Smile performs about 15,000 surgeries a year, improving the lives of just as many children all over the world. For us this is a smart choice for everyday healthcare and why Benvue International has supported Operation Smile.